1 |
0.5 mg budesonide effervescent tablet for orodispersible use |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
2 |
1 mg budesonide effervescent tablet for orodispersible use |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
3 |
1mg budesonide effervescent tablet for orodispersible use |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
4 |
2mg budesonide effervescent tablet for orodispersible use |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
5 |
5 mg montelukast |
Montelukast |
2件: D00529 D00529, D08229 D08229 💬 |
CYSLTR1 1件: CYSLTR1 💬 |
Calcium signaling pathway 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
6 |
Ak002 |
- |
- |
- |
- |
098 1件: 98 💬 |
7 |
Allergen |
- |
- |
- |
- |
098 1件: 98 💬 |
8 |
Allergy immunotherapy (allergy shots) |
- |
- |
- |
- |
098 1件: 98 💬 |
9 |
Antolimab |
- |
- |
- |
- |
098 1件: 98 💬 |
10 |
Apt-1011 |
- |
- |
- |
- |
098 1件: 98 💬 |
11 |
Apt-1011 - 3 mg |
- |
- |
- |
- |
098 1件: 98 💬 |
12 |
Barium |
Barium |
- |
- |
- |
019 2件: 19, 98 💬 |
13 |
Beclomethasone dipropionate |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 2件: 97, 98 💬 |
14 |
Behavioral: six-foods elimination diet |
- |
- |
- |
- |
098 1件: 98 💬 |
15 |
Benralizumab |
Benralizumab |
1件: D09874 D09874 💬 |
IL5RA 1件: IL5RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
044 4件: 44, 45, 98, 162 💬 |
16 |
Bethanechol |
Bethanechol |
1件: D01000 D01000 💬 |
CHRM1 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
098 1件: 98 💬 |
17 |
Budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
18 |
Budesonide 0.5mg orodispersible tablet twice daily |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
19 |
Budesonide 1mg orodispersible tablet twice daily |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
20 |
Budesonide [0.4mg/ml] viscous suspension |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
21 |
Budesonide oral suspension |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
22 |
Budesonide oral suspension [0.2 mg/ml] |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
23 |
Budesonide plus prevacid |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
24 |
Buet 0.5 mg |
- |
- |
- |
- |
098 1件: 98 💬 |
25 |
Buet 1mg |
- |
- |
- |
- |
098 1件: 98 💬 |
26 |
Buet 2mg |
- |
- |
- |
- |
098 1件: 98 💬 |
27 |
Buu 0.4mg/ml |
- |
- |
- |
- |
098 1件: 98 💬 |
28 |
Caly-002 |
- |
- |
- |
- |
098 1件: 98 💬 |
29 |
Cromolyn |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
002 3件: 2 , 85, 98 💬 |
30 |
Device: esophacap |
- |
- |
- |
- |
098 1件: 98 💬 |
31 |
Device: intraluminal impedance |
- |
- |
- |
- |
098 1件: 98 💬 |
32 |
Device: niox mino® airway inflammation monitor |
Methamidophos |
- |
- |
- |
098 1件: 98 💬 |
33 |
Device: novel allergen-specific immune signature directed approach to dietary elimination therapy |
- |
- |
- |
- |
098 1件: 98 💬 |
34 |
Dexlansoprazole |
Dexlansoprazole |
1件: D08903 D08903 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
098 1件: 98 💬 |
35 |
Diagnostic test: barium esophagram |
Barium |
- |
- |
- |
098 1件: 98 💬 |
36 |
Diagnostic test: bone mineral density (dexa) scan |
- |
- |
- |
- |
098 1件: 98 💬 |
37 |
Diagnostic test: endoscopy while on study drug |
- |
- |
- |
- |
098 1件: 98 💬 |
38 |
Diagnostic test: height measurement |
- |
- |
- |
- |
098 1件: 98 💬 |
39 |
Diagnostic test: physical examination and questionnaires |
- |
- |
- |
- |
098 1件: 98 💬 |
40 |
Diagnostic test: retrospective evaluation of endoscopy prior to study drug |
- |
- |
- |
- |
098 1件: 98 💬 |
41 |
Diagnostic test: vitamin d measurement |
Vitamin D |
- |
- |
- |
098 1件: 98 💬 |
42 |
Dupilumab |
Dupilumab |
1件: D10354 D10354 💬 |
IL4R 1件: IL4R 💬 |
Cytokine-cytokine receptor interaction 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
051 4件: 51, 98, 160, 162 💬 |
43 |
Dupilumab (blinded) |
Dupilumab |
1件: D10354 D10354 💬 |
IL4R 1件: IL4R 💬 |
Cytokine-cytokine receptor interaction 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
098 1件: 98 💬 |
44 |
Dupilumab (open-label) |
Dupilumab |
1件: D10354 D10354 💬 |
IL4R 1件: IL4R 💬 |
Cytokine-cytokine receptor interaction 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
098 1件: 98 💬 |
45 |
Dupixent |
- |
- |
- |
- |
098 3件: 98, 160, 162 💬 |
46 |
Eso-101 |
- |
- |
- |
- |
098 1件: 98 💬 |
47 |
Esomeprazole |
Esomeprazole |
4件: D01984 D01984, D04056 D04056, D07917 D07917, D09339 D09339 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
013 6件: 13, 46, 86, 98, 298, 299 💬 |
48 |
Eur-1100 |
- |
- |
- |
- |
098 1件: 98 💬 |
49 |
Famotidine |
Famotidine |
1件: D00318 D00318 💬 |
HRH2 1件: HRH2 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction |
006 4件: 6 , 46, 86, 98 💬 |
50 |
Florence 30 µg/ml |
- |
- |
- |
- |
098 1件: 98 💬 |
51 |
Florence 60 µg/ml |
- |
- |
- |
- |
098 1件: 98 💬 |
52 |
Florence 90 µg/ml |
- |
- |
- |
- |
098 1件: 98 💬 |
53 |
Flovent |
- |
- |
- |
- |
098 1件: 98 💬 |
54 |
Fluticasone |
Fluticasone |
1件: D07981 D07981 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 3件: 98, 228, 299 💬 |
55 |
Fluticasone mdi |
Fluticasone |
1件: D07981 D07981 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
56 |
Fluticasone propionate |
Fluticasone |
2件: D01708 D01708, D07981 D07981 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 2件: 98, 228 💬 |
57 |
Fluticasone propionate, 800 mcg twice daily (post 4fed failure) |
Fluticasone |
2件: D01708 D01708, D07981 D07981 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
58 |
Fluticasone propionate, 880 mcg twice daily (after 6fed failure) |
Fluticasone |
2件: D01708 D01708, D07981 D07981 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
59 |
Fluticasone propionate, usp |
Fluticasone |
2件: D01708 D01708, D07981 D07981 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
60 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
61 |
High dose budesonide suspension |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
62 |
High dose budesonide tablet |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
63 |
Honey |
Honey |
1件: D06776 D06776 💬 |
- |
- |
057 3件: 57, 98, 299 💬 |
64 |
Infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
65 |
Inhaled/swallowed budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
66 |
Intubated with propofol (ip) |
Propofol |
1件: D00549 D00549 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
098 1件: 98 💬 |
67 |
Intubated with sevoflurane (is) |
Sevoflurane |
1件: D00547 D00547 💬 |
- |
- |
098 1件: 98 💬 |
68 |
Lansoprazole |
Lansoprazole |
1件: D00355 D00355 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 7件: 63, 71, 85, 98, 166, 222, 299 💬 |
69 |
Lirentelimab |
- |
- |
- |
- |
098 1件: 98 💬 |
70 |
Lirentelimab (ak002) |
- |
- |
- |
- |
098 1件: 98 💬 |
71 |
Loratadine |
Loratadine |
1件: D00364 D00364 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 3件: 13, 46, 98 💬 |
72 |
Losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
73 |
Losartan potassium |
Losartan |
3件: D00357 D00357, D08146 D08146, D08403 D08403 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
036 5件: 36, 98, 167, 179, 215 💬 |
74 |
Low dose budesonide tablet |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
75 |
Medi-563 |
- |
- |
- |
- |
044 3件: 44, 45, 98 💬 |
76 |
Mepolizumab |
Mepolizumab |
1件: D04923 D04923 💬 |
IL5 1件: IL5 💬 |
Allograft rejection 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
044 4件: 44, 45, 98, 162 💬 |
77 |
Mepolizumab 100 mg |
Mepolizumab |
1件: D04923 D04923 💬 |
IL5 1件: IL5 💬 |
Allograft rejection 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
098 1件: 98 💬 |
78 |
Mepolizumab 300 mg |
Mepolizumab |
1件: D04923 D04923 💬 |
IL5 1件: IL5 💬 |
Allograft rejection 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
098 1件: 98 💬 |
79 |
Milk |
Cow milk |
- |
- |
- |
098 2件: 98, 210 💬 |
80 |
Mometasone |
Mometasone |
3件: D00690 D00690, D03325 D03325, D08227 D08227 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 2件: 98, 162 💬 |
81 |
Mometasone furoate |
Mometasone |
3件: D00690 D00690, D03325 D03325, D08227 D08227 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 2件: 98, 162 💬 |
82 |
Monitor |
Methamidophos |
- |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
83 |
Montelukast |
Montelukast |
2件: D00529 D00529, D08229 D08229 💬 |
CYSLTR1 1件: CYSLTR1 💬 |
Calcium signaling pathway 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction |
013 5件: 13, 46, 85, 98, 228 💬 |
84 |
Montelukast/ singulair |
Montelukast |
2件: D00529 D00529, D08229 D08229 💬 |
CYSLTR1 1件: CYSLTR1 💬 |
Calcium signaling pathway 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
85 |
Nasonex |
- |
- |
- |
- |
098 1件: 98 💬 |
86 |
Nitric oxide |
Nitric Oxide |
1件: D00074 D00074 💬 |
- |
- |
046 8件: 46, 85, 86, 98, 210, 251, 294, 299 💬 |
87 |
Oc000459 |
- |
- |
- |
- |
098 1件: 98 💬 |
88 |
Omalizumab |
Omalizumab |
1件: D05251 D05251 💬 |
FCER1A 1件: FCER1A 💬 |
Asthma 4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway |
046 7件: 46, 53, 65, 98, 162, 226, 299 💬 |
89 |
Omeprazole |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
90 |
Omeprazole 20mg bid |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
098 1件: 98 💬 |
91 |
Oral budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
92 |
Oral budesonide suspension (mb-9) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
93 |
Oral budesonide suspension (obs) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
94 |
Oral cromolyn sodium |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
098 1件: 98 💬 |
95 |
Oral viscous budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
96 |
Oral viscous budesonide (ovb) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
97 |
Other: 1 food elimination diet |
- |
- |
- |
- |
098 1件: 98 💬 |
98 |
Other: 1 food elimination diet therapy |
- |
- |
- |
- |
098 1件: 98 💬 |
99 |
Other: 4 food elimination diet |
- |
- |
- |
- |
098 1件: 98 💬 |
100 |
Other: 4 food elimination diet (post 1fed failure) |
- |
- |
- |
- |
098 1件: 98 💬 |
101 |
Other: 6 food elimination diet (after 1fed failure) |
- |
- |
- |
- |
098 1件: 98 💬 |
102 |
Other: 6 food elimination diet therapy |
- |
- |
- |
- |
098 1件: 98 💬 |
103 |
Other: antigen (wheat base soy sauce) spray |
Wheat |
1件: D06902 D06902 💬 |
- |
- |
098 1件: 98 💬 |
104 |
Other: assessment of medication compliance |
- |
- |
- |
- |
098 1件: 98 💬 |
105 |
Other: d-xylose |
Xylose |
1件: D06346 D06346 💬 |
- |
- |
098 1件: 98 💬 |
106 |
Other: elimination diet |
- |
- |
- |
- |
098 1件: 98 💬 |
107 |
Other: honey |
Honey |
1件: D06776 D06776 💬 |
- |
- |
098 1件: 98 💬 |
108 |
Other: medication compliance phone call |
- |
- |
- |
- |
098 1件: 98 💬 |
109 |
Other: oral nitric oxide testing |
Nitric Oxide |
1件: D00074 D00074 💬 |
- |
- |
098 1件: 98 💬 |
110 |
Other: saline |
- |
- |
- |
- |
002 8件: 2 , 6 , 46, 97, 98, 256, 274, 301 💬 |
111 |
Other: symptom survey |
- |
- |
- |
- |
098 1件: 98 💬 |
112 |
Other: xanthan gum |
Xanthan gum |
1件: D06333 D06333 💬 |
- |
- |
098 1件: 98 💬 |
113 |
Potassium |
Potassium |
1件: D08403 D08403 💬 |
- |
- |
036 10件: 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
114 |
Procedure: esophageal dilation |
- |
- |
- |
- |
098 1件: 98 💬 |
115 |
Procedure: esophagogastroduodenoscopy |
- |
- |
- |
- |
098 1件: 98 💬 |
116 |
Procedure: intraluminal impedance |
- |
- |
- |
- |
098 1件: 98 💬 |
117 |
Propofol |
Propofol |
1件: D00549 D00549 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 8件: 6 , 21, 22, 34, 46, 84, 98, 296 💬 |
118 |
Qax576 |
- |
- |
- |
- |
051 4件: 51, 85, 96, 98 💬 |
119 |
Radiation: computerized tomography scan |
- |
- |
- |
- |
098 1件: 98 💬 |
120 |
Radiation: esophageal barium xray |
Barium |
- |
- |
- |
098 1件: 98 💬 |
121 |
Radiation: planar images |
- |
- |
- |
- |
098 1件: 98 💬 |
122 |
Radiation: single photon emission computed tomography scans |
- |
- |
- |
- |
098 1件: 98 💬 |
123 |
Reslizumab |
Reslizumab |
1件: D08985 D08985 💬 |
IL5 1件: IL5 💬 |
Allograft rejection 13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation |
044 2件: 44, 98 💬 |
124 |
Rpc4046 |
- |
- |
- |
- |
098 1件: 98 💬 |
125 |
Sb-240563 |
- |
- |
- |
- |
044 3件: 44, 45, 98 💬 |
126 |
Sch55700 |
- |
- |
- |
- |
098 1件: 98 💬 |
127 |
Sevoflurane |
Sevoflurane |
1件: D00547 D00547 💬 |
- |
- |
006 6件: 6 , 21, 22, 34, 98, 296 💬 |
128 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
129 |
Steroid and proton pump inhibitor therapy |
- |
- |
- |
- |
098 1件: 98 💬 |
130 |
Sucralfate |
Sucralfate |
1件: D00446 D00446 💬 |
- |
- |
098 1件: 98 💬 |
131 |
Swallowed fluticasone |
Fluticasone |
1件: D07981 D07981 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
132 |
Technetium tc 99m |
Technetium Tc-99m |
- |
- |
- |
046 2件: 46, 98 💬 |
133 |
Treat with lansoprazole 30 mg bid for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms |
Lansoprazole |
1件: D00355 D00355 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
098 1件: 98 💬 |
134 |
Viaskin milk 500 mcg |
Cow milk |
- |
- |
- |
098 1件: 98 💬 |
135 |
Viscous/swallowed budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
098 1件: 98 💬 |
136 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 21件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
137 |
Vonoprazan |
Vonoprazan |
1件: D11784 D11784 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 2件: 63, 98 💬 |
138 |
Wheat |
Wheat |
1件: D06902 D06902 💬 |
- |
- |
098 2件: 98, 266 💬 |
139 |
Xanthan gum |
Xanthan gum |
1件: D06333 D06333 💬 |
- |
- |
098 1件: 98 💬 |
140 |
Xylose |
Xylose |
1件: D06346 D06346 💬 |
- |
- |
098 1件: 98 💬 |
141 |
Zofran - no intubation |
- |
- |
- |
- |
098 1件: 98 💬 |